| News

Switzerland Innovation Park Basel Area Site Novartis Campus

30.06.2020

We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis Campus dedicated to digital health provides a focal point to a unique community of digital healthcare experts.

Novartis Campus
Novartis Campus in Basel (img: Mark Niedermann)

In addition to being positioned at the very heart of the Novartis Campus, the site offers fix desks as well as flex desks, a workshop area, an agile workplace and a meeting area. The open space stimulates collaboration.

We particularly invite startups and companies active in the field of digital healthcare and personalized medicine to get in touch with our Community Manager Rahel Schneider to visit our site of the Switzerland Innovation Park Basel Area at the Novartis Campus.

The Switzerland Innovation Park Basel Area maintains four sites, located in Allschwil, Basel and Delémont. The site at the Novartis Campus is the latest addition. In January, the pharmaceutical company communicated the opening of the Campus. Basel Area Business & Innovation with the Switzerland Innovation Park Basel Area is the first external organization to move onto the Campus. The Switzerland Innovation Park Basel Area belongs to the national network of Switzerland Innovation, striving to offer the best place for technology-driven companies to develop their next product and providing easy access to talents, knowledge and expertise.

Share this article

Do you have a question? We'd like to hear from you.

You may also be interested in

Roche launches new coronavirus antibody test
Basel Area Business & Innovation, Innovation, Invest

Roche launches new coronavirus antibody test

Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development...

Read More
Investors see great potential in Polyneuron
Basel Area Business & Innovation, Innovation, Invest

Investors see great potential in Polyneuron

The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million...

Read More
Lonza set to manufacture coronavirus drug for Humanigen
Basel Area Business & Innovation, Innovation, Invest

Lonza set to manufacture coronavirus drug for Humanigen

The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...

Read More
Startups from the Basel Area ranked among the best
Basel Area Business & Innovation, Innovation, Switzerland Innovation Park

Startups from the Basel Area ranked among the best

Startups from the Basel Area have been ranked highly in the TOP 100 Swiss Startup Award by Venturelab. The medtech...

Read More
Roche testing for coronavirus and flu simultaneously
Basel Area Business & Innovation, Innovation, Invest

Roche testing for coronavirus and flu simultaneously

The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that...

Read More
Hengrui Medicine sets up clinical research and development in Basel
Basel Area Business & Innovation, Innovation, Invest

Hengrui Medicine sets up clinical research and development in Basel

The Chinese life sciences company Hengrui Medicine is establishing a Swiss subsidiary in Basel. The European hub for clinical research...

Read More
1 2 3 34

Do you have a question? We'd like to hear from you.